Status:
COMPLETED
Brillant Blue Versus Indocyanine Green for Macular Hole Surgery
Lead Sponsor:
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Conditions:
Idiopathic Macular Holes
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Macular Hole Surgery with two different Dyes
Eligibility Criteria
Inclusion
- Idiopathic stage 3 and 4 macular holes
- Stage 2 macular holes, followed up for at least 6 months
- Pseudophakic and phakic eyes
- Age over 60 years
Exclusion
- Traumatic macular holes
- Secondary macular holes
- Severe ocular diseases
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00757471
Start Date
August 1 2008
End Date
August 1 2015
Last Update
January 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser surgery
Vienna, Vienna, Austria, 1030